يعرض 1 - 20 نتائج من 41 نتيجة بحث عن '"Lawrence Davies"', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1

    المصدر: Annals of Oncology
    Saturno, G, Lopes, F, Niculescu-Duvaz, I, Niculescu-Duvaz, D, Zambon, A, Davies, L, Johnson, L, Preece, N, Lee, R, Viros Usandizaga, A, Holovanchuk, D, Pedersen, M, Mcleary, R, Lorigan, P, Dhomen, N, Fisher, C, Banerji, U, Dean, E, Krebs, M, Gore, M, Larkin, J, Marais, R & Springer, C 2021, ' The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers ', Annals of Oncology, vol. 32, no. 2, pp. 269-278 . https://doi.org/10.1016/j.annonc.2020.10.483

  2. 2
  3. 3
  4. 4
    eBook
  5. 5
  6. 6
  7. 7

    المصدر: Cancer Cell
    Girotti, M R, Lopes, F, Preece, N, Niculescu-Duvaz, D, Zambon, A, Davies, L, Whittaker, S, Saturno, G, Viros, A, Pedersen, M, Suijkerbuijk, B M J M, Menard, D, McLeary, R, Johnson, L, Fish, L, Ejiama, S, Sanchez-Laorden, B, Hohloch, J, Carragher, N, Macleod, K, Ashton, G, Marusiak, A A, Fusi, A, Brognard, J, Frame, M, Lorigan, P, Marais, R & Springer, C 2015, ' Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma ', Cancer Cell, vol. 27, no. 1, pp. 85-96 . https://doi.org/10.1016/j.ccell.2014.11.006
    Girotti, MR, Lopes, F, Preece, N, Niculescu-Duvaz, D, Zambon, A, Davies, L, Whittaker, S, Saturno, G, Viros, A, Pedersen, M, Suijkerbuijk, BM J M, Menard, D, McLeary, R, Johnson, L, Fish, L, Ejiama, S, Sanchez-Laorden, B, Hohloch, J, Carragher, N, Macleod, K, Ashton, G, Marusiak, AA, Fusi, A, Brognard, J, Frame, M, Lorigan, P, Marais, R & Springer, C 2015, ' Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma. ', Cancer Cell, vol. 27, no. 1, pp. 85-96 . https://doi.org/10.1016/j.ccell.2014.11.006, https://doi.org/10.1016/j.ccell.2014.11.006

    وصف الملف: application/pdf

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    المصدر: Dean, E, Banerji, U, Girotti, R, Niculescu-Duvaz, I, Lopes, F, Davies, L, Niculescu-Duvaz, D, Dhomen, N, Ellis, S, Ali, Z, O'Carrigan, B, Carter, L, Chisolm, L, Dive, C, Lane, HA, Lorigan, P, Gore, ME, Larkin, J, Marais, R & Springer, C 2016, A Phase 1 first-in-human trial to evaluate the safety and tolerability of CCT3833, an oral panRAF inhibitor, in patients with advanced solid tumours, including metastatic melanoma. in Journal of Clinical Oncology . suppl; abstr TPS9597 edn, vol. 34 . < http://meetinglibrary.asco.org/content/168123-176 >
    University of Manchester-PURE

  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20